CD274 and neoplasm: Another study in the field, albeit at a different tumor and with different therapeutic agents, was recently published by Cvetkovic et al. The authors studied a group of patients with advanced NSCLC treated with anti-PD-1/PD-L1 monotherapy or in combination with chemotherapy, and found that a lower colon [18F]FDG uptake on PET/CT at baseline was associated with better clinical outcomes [58].